Skip to main content
. 2024 May 18;12(5):551. doi: 10.3390/vaccines12050551

Table 4.

Estimates of variables correlated to COVID-19 vaccine propensity.

IBD Patients
n = 77 (43.3%)
Control Group
n = 101 (56.7%)
Differences
between Correlations
Correlation Estimate (95% CI) p-Value Correlation Estimate (95% CI) p-Value p-Value
I am vaccinated against COVID-19 0.16 (−0.06 to 0.38) 0.1603 −0.27 (−0.27 to −0.08) 0.0057 0.002
Vaccines can prevent severe illness 0.60 (0.43 to 0.73) <0.0001 0.43 (0.25 to 0.58) <0.0001 0.07
COVID-19 vaccination will make the pandemic end sooner 0.73 (0.60 to 0.83) <0.0001 0.64 (0.50 to 0.75) <0.0001 0.135
I believe in COVID-19 vaccine effectiveness 0.77 (0.65 to 0.85) <0.0001 0.69 (0.57 to 0.78) <0.0001 0.153
I’m concerned about the safety of COVID-19 vaccination in IBD −0.28 (−0.48 to −0.04) 0.0202
COVID-19 vaccination may trigger IBD flares −0.28 (−0.48 to −0.04) 0.0192
Type of IBD 0.07 (−0.16 to−0.30) 0.5479
CD location 0.28 (−0.05 to 0.56) 0.0962
UC extension −0.15 (−0.46 to 0.19) 0.3902
Years of disease 0.12 (−0.11 to 0.35) 0.2967
IBD activity −0.13 (−0.36 to 0.09) 0.2475
Treatment 0.08 (−0.15 to 0.31) 0.4985